This is an aggregated industry headline. Read the full story at PharmaVoice →
Brand-name drug denials are surging, especially for weight-loss
Nearly one-third of prescriptions included in a new study were rejected the first time a patient attempted to fill them.
By PharmaVoice
· Jul 28, 2026
· via PharmaVoice
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Reporting a new miss in one indication, Karyopharm is plowing ahead with plans to advance its XPO1 inhibitor X…
The WeekFierceBiotech ↗
Whether it's looming tariff threats or the rise of China, you need a truly global view to navigate today's bio…
The WeekBriefing
AbbVie’s Skyrizi generated $5.55 billion in second-quarter sales, nearly matching Humira’s best quarter. The r…